1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
388.35 -21.65 (-5.28%)
12.6M

NSE 04 Dec, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Analyst Buy
Axis Direct maintains its 'Buy' rating on Biocon, expects a revenue CAGR of 19.8% over FY26-27 See details